In 2008, approximately 11,000 women in the United States will be diagnosed with cervical cancer and more than 3,800 American women will die of this disease. The recent approval by the Food and Drug Administration of a human papillomavirus (HPV) vaccine that is over 90% effective in preventing new infections and precancerous cervical lesions caused by the HPV types that cause cervical cancer may possibly reduce the incidence of cervical cancer. However, a number of unresolved issues exist regarding this vaccine. This paper will explore considerations and challenges facing healthcare educators regarding the HPV vaccine in the following areas: (a) demographic, (b) social, (c) economic, (d) ethical, and (e) political.
Davis-Wolfe M, Garbani N, Hay-Thompson S, Mayer S, Roane CS. A Health Care Education and Promotion Challenge: HPV Vaccination. The Internet Journal of Allied Health Sciences and Practice. 2009 Jan 01;7(1), Article 7.